Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Takeda, PwC to Develop App for Crohn’s Disease
September 13, 2019
- MSD Files HIV-1 Drug Doravirine in Japan
September 13, 2019
- Chugai’s Satralizumab Hits Primary Target in PIII Study
September 13, 2019
- IT Startup Activaid Offers Clinical Trial Matching Service for IBD Patients through App
September 12, 2019
- Opdivo Showed 5-Year Survival Rates of 13.4% in 2nd-Line NSCLC in PIII Studies
September 12, 2019
- Fujifilm Rolls Out iPS Cell-Derived Small Intestinal Cell in Japan for Use in Assessing Drug Absorption
September 12, 2019
- Full Approval in Japan Will Be 1st Goal for Collategene: AnGes Chief
September 11, 2019
- Vital-Net Carving Out New Businesses in Regenerative Medicine, Robotics
September 11, 2019
- Keytruda Filed for Esophageal Cancer in Japan
September 11, 2019
- Wakamoto Casts Off Glaucoma Hopeful on Safety Worries
September 11, 2019
- Daiichi Sankyo Presents Updated PI Data of ADCs DS-1062, U3-1402 for NSCLC
September 11, 2019
- 1st RNAi Therapy Onpattro Makes Japan Debut
September 10, 2019
- Daiichi Sankyo’s Big-Seller Hopeful DS-8201 Filed in Japan
September 10, 2019
- Japan Lung Cancer Market to Surge to 317.5 Billion Yen in 2027: Fuji Keizai
September 10, 2019
- Japan Ethical Drug Sales Zoom 7.0% in July: Crecon
September 9, 2019
- Shonan iPark Kicks Off Demonstration Experiment Seeking “Mibyo” Business Opportunities
September 9, 2019
- Meiji Seika’s Schizophrenia Treatment ME2112 Misses Primary Goal in Japan PIII Study
September 9, 2019
- EA Pharma Obtains Global Rights for Glycolipid Compound from National Neurology Center
September 9, 2019
- Takeda Launches US Recall of Natpara Parathyroid Hormone
September 9, 2019
- Lonsurf Gets European Nod for Gastric Cancer
September 9, 2019
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…